Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. (Q46518412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Gian Marco Leggio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Gian Marco Leggio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Vincenzo Di Marzo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Vincenzo Micale

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Luigia Cristino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Alessandra Tamburella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Stefania Petrosino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

25 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

593-606

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18580871%20AND%20SRC:MED&resulttype=core&format=json

Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Development of the first potent and specific inhibitors of endocannabinoid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

FAAH and anandamide: is 2-AG really the odd one out?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Role of endogenous cannabinoids in synaptic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Endocannabinoid mechanisms of pain modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Fatty acids and immune responses--a new perspective in searching for clues to mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Effects of the vanilloid agonist olvanil and antagonist capsazepine on rat behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain: neuroprotection versus neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Differences in anxiety-related behavior and response to diazepam in BALB/cByJ and C57BL/6J strains of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

The endocannabinoid system and extinction learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid typ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

The endogenous cannabinoid system controls extinction of aversive memories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Are the anxiogenic effects of yohimbine mediated by its action at benzodiazepine receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Biochemistry and pharmacology of endovanilloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Endocannabinoid system and synaptic plasticity: implications for emotional responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

Usefulness of animal models with newer anxiolytics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

inferred from DOI database lookup

7 January 2021

based on heuristic

A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98

inferred from DOI database lookup

7 January 2021

based on heuristic

Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST)

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.98